M1 | M2 | |||
---|---|---|---|---|
pEC50 | EMAX | pEC50 | EMAX | |
% above basal | % above basal | |||
Without preincubation | ||||
Xanomeline | 8.04 ± 0.01* | 228 ± 9* | N.E. | N.E. |
Carbachol | 6.08 ± 0.01 | 179 ± 7 | 6.12 ± 0.05 | 187 ± 0.06 |
+ 3 nM xanomeline | 5.97 ± 0.03* | 179 ± 8 | N.M. | N.M. |
+ 10 nM xanomeline | 5.79 ± 0.04* | 183 ± 7 | 6.01 ± 0.05 | 186 ± 0.06 |
+ 30 nM xanomeline | 5.39 ± 0.01* | 184 ± 8 | 5.89 ± 0.03* | 185 ± 0.09 |
+ 100 nM xanomeline | 5.02 ± 0.02* | 184 ± 9 | 5.63 ± 0.02* | 182 ± 0.08 |
+ 300 nM xanomeline | N.M. | N.M. | 5.16 ± 0.05* | 196 ± 0.09 |
With 60-min preincubation | ||||
Xanomeline | 8.15 ± 0.04* | 224 ± 6* | 7.78 ± 0.03 | 75 ± 5* |
Carbachol | 6.08 ± 0.04 | 189 ± 6 | 6.12 ± 0.03 | 188 ± 6 |
+ 3 nM xanomeline | 5.92 ± 0.04* | 189 ± 7 | N.M. | N.M. |
+ 10 nM xanomeline | 5.68 ± 0.03* | 189 ± 8 | 6.02 ± 0.01 | 191 ± 7 |
+ 30 nM xanomeline | 5.32 ± 0.03* | 195 ± 9 | 5.68 ± 0.02* | 197 ± 8 |
+ 100 nM xanomeline | 4.91 ± 0.03* | 194 ± 11 | 5.28 ± 0.03* | 190 ± 8 |
+ 300 nM xanomeline | N.M. | N.M. | 4.97 ± 0.04* | 194 ± 7 |
With 60-min preincubation followed by washing | ||||
Xanomeline | 5.98 ± 0.03 | 208 ± 6* | 5.81 ± 0.03* | 62 ± 5* |
Carbachol | 6.07 ± 0.03 | 186 ± 6 | 6.06 ± 0.03 | 195 ± 6 |
+ 0.3 μM xanomeline | 6.08 ± 0.04 | 189 ± 7 | 6.04 ± 0.04 | 190 ± 8 |
+ 1 μM xanomeline | 6.18 ± 0.01 | 187 ± 9 | 6.07 ± 0.05 | 181 ± 9 |
+ 3 μM xanomeline | 5.84 ± 0.05* | 194 ± 8 | 6.01 ± 0.02 | 173 ± 7* |
+ 10 μM xanomeline | 5.42 ± 0.05* | 178 ± 9 | 5.86 ± 0.01* | 165 ± 7* |
N.E., no effect; N.M., not measured.
↵* P < 0.05, significantly different from carbachol or carbachol alone by t test or ANOVA followed by Dunnett's test.